Deals / Acquisition
Celgene acquired by Bristol Myers Squibb for 74 Billion USD
Deal value
$74.0 B
Year
2019
Stake
100%
Summary
Celgene acquired by Bristol Myers Squibb for 74 Billion USD.
Celgene is a Bio-Pharmaceutical company and headquarters is in New Jersey, USA.
Bristol-Myers Squibb is USA based health care and pharmaceutical multi-national company. Headquarters is in New York, USA.
Details
- Type
- Acquisition
- Buyer
- Bristol-Myers Squibb
- Buyer headquarters
- USA
- Year
- 2019
- Stake acquired
- 100%
- Website
- bms.com